A citation-based method for searching scientific literature

Razan Sheta, Magdalena Bachvarova, Marie Plante, Marie-Claude Renaud, Alexandra Sebastianelli, Jean Gregoire, Jamilet Miranda Navarro, Ricardo Bringas Perez, Jean-Yves Masson, Dimcho Bachvarov. J Transl Med 2020
Times Cited: 4







List of co-cited articles
6 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


3D tumor spheroids as in vitro models to mimic in vivo human solid tumors resistance to therapeutic drugs.
Ana S Nunes, Andreia S Barros, Elisabete C Costa, André F Moreira, Ilídio J Correia. Biotechnol Bioeng 2019
228
50

Three-dimensional cell culture systems and their applications in drug discovery and cell-based biosensors.
Rasheena Edmondson, Jessica Jenkins Broglie, Audrey F Adcock, Liju Yang. Assay Drug Dev Technol 2014
50

2D and 3D cell cultures - a comparison of different types of cancer cell cultures.
Marta Kapałczyńska, Tomasz Kolenda, Weronika Przybyła, Maria Zajączkowska, Anna Teresiak, Violetta Filas, Matthew Ibbs, Renata Bliźniak, Łukasz Łuczewski, Katarzyna Lamperska. Arch Med Sci 2018
321
50

Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase.
Helen E Bryant, Niklas Schultz, Huw D Thomas, Kayan M Parker, Dan Flower, Elena Lopez, Suzanne Kyle, Mark Meuth, Nicola J Curtin, Thomas Helleday. Nature 2005
50

Homologous Recombination Deficiency: Exploiting the Fundamental Vulnerability of Ovarian Cancer.
Panagiotis A Konstantinopoulos, Raphael Ceccaldi, Geoffrey I Shapiro, Alan D D'Andrea. Cancer Discov 2015
405
50

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy.
Hannah Farmer, Nuala McCabe, Christopher J Lord, Andrew N J Tutt, Damian A Johnson, Tobias B Richardson, Manuela Santarosa, Krystyna J Dillon, Ian Hickson, Charlotte Knights,[...]. Nature 2005
50

The MEK/ERK cascade: from signaling specificity to diverse functions.
Yoav D Shaul, Rony Seger. Biochim Biophys Acta 2007
633
25


Toward the Broad Adoption of 3D Tumor Models in the Cancer Drug Pipeline.
Megan C Cox, Laura M Reese, Lissett R Bickford, Scott S Verbridge. ACS Biomater Sci Eng 2015
34
25

Drug discovery: How melanomas bypass new therapy.
David Solit, Charles L Sawyers. Nature 2010
39
25

COT drives resistance to RAF inhibition through MAP kinase pathway reactivation.
Cory M Johannessen, Jesse S Boehm, So Young Kim, Sapana R Thomas, Leslie Wardwell, Laura A Johnson, Caroline M Emery, Nicolas Stransky, Alexandria P Cogdill, Jordi Barretina,[...]. Nature 2010
25

BRAF plus MEK-targeted drugs: a new standard of treatment for BRAF-mutant advanced melanoma.
Paola Queirolo, Francesco Spagnolo. Cancer Metastasis Rev 2017
24
25

Melanoma Therapeutic Strategies that Select against Resistance by Exploiting MYC-Driven Evolutionary Convergence.
Katherine R Singleton, Lorin Crawford, Elizabeth Tsui, Haley E Manchester, Ophelia Maertens, Xiaojing Liu, Maria V Liberti, Anniefer N Magpusao, Elizabeth M Stein, Jennifer P Tingley,[...]. Cell Rep 2017
42
25

Molecular pathways: mitogen-activated protein kinase pathway mutations and drug resistance.
Antonia L Pritchard, Nicholas K Hayward. Clin Cancer Res 2013
59
25

Rab proteins as membrane organizers.
M Zerial, H McBride. Nat Rev Mol Cell Biol 2001
25


BRAF and MEK Inhibitors: Use and Resistance in BRAF-Mutated Cancers.
Jaquelyn N Sanchez, Ton Wang, Mark S Cohen. Drugs 2018
51
25

Five-Year Analysis of Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma.
Reinhard Dummer, Axel Hauschild, Mario Santinami, Victoria Atkinson, Mario Mandalà, John M Kirkwood, Vanna Chiarion Sileni, James Larkin, Marta Nyakas, Caroline Dutriaux,[...]. N Engl J Med 2020
101
25

Encorafenib in combination with binimetinib for unresectable or metastatic melanoma with BRAF mutations.
Claudia Trojaniello, Lucia Festino, Vito Vanella, Paolo A Ascierto. Expert Rev Clin Pharmacol 2019
27
25

Downregulation of CPA4 inhibits non small-cell lung cancer growth by suppressing the AKT/c-MYC pathway.
Yangyang Fu, Lihuang Su, Mengsi Cai, Boyang Yao, Sisi Xiao, Qinlian He, Le Xu, Lehe Yang, Chengguang Zhao, Tingting Wan,[...]. Mol Carcinog 2019
10
25

Rab family of small GTPases: an updated view on their regulation and functions.
Yuta Homma, Shu Hiragi, Mitsunori Fukuda. FEBS J 2021
68
25

New aspects of amino acid metabolism in cancer.
Lisa Vettore, Rebecca L Westbrook, Daniel A Tennant. Br J Cancer 2020
92
25

Targeting Rac and Cdc42 GTPases in Cancer.
María Del Mar Maldonado, Suranganie Dharmawardhane. Cancer Res 2018
115
25

Nicotinamide N‑methyltransferase induces the proliferation and invasion of squamous cell carcinoma cells.
Young-Sool Hah, Hee Young Cho, Sun Young Jo, Young Sook Park, Eun Phil Heo, Tae-Jin Yoon. Oncol Rep 2019
10
25

Phase I trial with the CD44v6-targeting immunoconjugate bivatuzumab mertansine in head and neck squamous cell carcinoma.
Herbert Riechelmann, Alexander Sauter, Wolfram Golze, Gertraud Hanft, Carsten Schroen, Karl Hoermann, Thomas Erhardt, Silke Gronau. Oral Oncol 2008
110
25

Targeting mTOR signaling overcomes acquired resistance to combined BRAF and MEK inhibition in BRAF-mutant melanoma.
Beike Wang, Wei Zhang, Gao Zhang, Lawrence Kwong, Hezhe Lu, Jiufeng Tan, Norah Sadek, Min Xiao, Jie Zhang, Marilyne Labrie,[...]. Oncogene 2021
8
25

The PRIDE database and related tools and resources in 2019: improving support for quantification data.
Yasset Perez-Riverol, Attila Csordas, Jingwen Bai, Manuel Bernal-Llinares, Suresh Hewapathirana, Deepti J Kundu, Avinash Inuganti, Johannes Griss, Gerhard Mayer, Martin Eisenacher,[...]. Nucleic Acids Res 2019
25

Quantitative Proteomic and Phosphoproteomic Comparison of 2D and 3D Colon Cancer Cell Culture Models.
Xiaoshan Yue, Jessica K Lukowski, Eric M Weaver, Susan B Skube, Amanda B Hummon. J Proteome Res 2016
36
25

First-in-Class ERK1/2 Inhibitor Ulixertinib (BVD-523) in Patients with MAPK Mutant Advanced Solid Tumors: Results of a Phase I Dose-Escalation and Expansion Study.
Ryan J Sullivan, Jeffrey R Infante, Filip Janku, Deborah Jean Lee Wong, Jeffrey A Sosman, Vicki Keedy, Manish R Patel, Geoffrey I Shapiro, James W Mier, Anthony W Tolcher,[...]. Cancer Discov 2018
189
25


Role of matrix metalloproteinases (MMPs) in colorectal cancer.
Stanley Zucker, Jeffrey Vacirca. Cancer Metastasis Rev 2004
374
25

SLC transporters as therapeutic targets: emerging opportunities.
Lawrence Lin, Sook Wah Yee, Richard B Kim, Kathleen M Giacomini. Nat Rev Drug Discov 2015
331
25

Regulatory mechanisms and function of ERK MAP kinases.
Satoru Torii, Kei Nakayama, Takuya Yamamoto, Eisuke Nishida. J Biochem 2004
98
25

Targeting Autophagy in BRAF-Mutant Tumors.
Andrew Thorburn, Michael J Morgan. Cancer Discov 2015
11
25

Targeting RAS/RAF/MEK/ERK signaling in metastatic melanoma.
Ao-Xue Wang, Xiao-Yi Qi. IUBMB Life 2013
44
25

Phenformin as an Anticancer Agent: Challenges and Prospects.
Mª Eugenia García Rubiño, Esmeralda Carrillo, Gloria Ruiz Alcalá, Alicia Domínguez-Martín, Juan A Marchal, Houria Boulaiz. Int J Mol Sci 2019
28
25

Glutathione transferases: substrates, inihibitors and pro-drugs in cancer and neurodegenerative diseases.
Nerino Allocati, Michele Masulli, Carmine Di Ilio, Luca Federici. Oncogenesis 2018
199
25

Absolute quantitation of endogenous proteins with precision and accuracy using a capillary Western system.
Jin-Qiu Chen, Madeleine R Heldman, Michelle A Herrmann, Noemi Kedei, Wonhee Woo, Peter M Blumberg, Paul K Goldsmith. Anal Biochem 2013
73
25

BRAF mutant colorectal cancer: prognosis, treatment, and new perspectives.
E Sanz-Garcia, G Argiles, E Elez, J Tabernero. Ann Oncol 2017
113
25

The mitochondrial ADP/ATP carrier (SLC25 family): pathological implications of its dysfunction.
Benjamin Clémençon, Marion Babot, Véronique Trézéguet. Mol Aspects Med 2013
66
25

Positive- and negative-feedback regulations coordinate the dynamic behavior of the Ras-Raf-MEK-ERK signal transduction pathway.
Sung-Young Shin, Oliver Rath, Sang-Mok Choo, Frances Fee, Brian McFerran, Walter Kolch, Kwang-Hyun Cho. J Cell Sci 2009
125
25

Pharmacological targeting and the diverse functions of the metastasis suppressor, NDRG1, in cancer.
Kyung Chan Park, Jasmina Paluncic, Zaklina Kovacevic, Des R Richardson. Free Radic Biol Med 2020
16
25


Semi-supervised learning for peptide identification from shotgun proteomics datasets.
Lukas Käll, Jesse D Canterbury, Jason Weston, William Stafford Noble, Michael J MacCoss. Nat Methods 2007
25

Models for the functions of Arf GAPs.
Michael P East, Richard A Kahn. Semin Cell Dev Biol 2011
50
25


Targeting mitochondrial biogenesis to overcome drug resistance to MAPK inhibitors.
Gao Zhang, Dennie T Frederick, Lawrence Wu, Zhi Wei, Clemens Krepler, Satish Srinivasan, Young Chan Chae, Xiaowei Xu, Harry Choi, Elaida Dimwamwa,[...]. J Clin Invest 2016
165
25


Overall Survival and Durable Responses in Patients With BRAF V600-Mutant Metastatic Melanoma Receiving Dabrafenib Combined With Trametinib.
Georgina V Long, Jeffrey S Weber, Jeffrey R Infante, Kevin B Kim, Adil Daud, Rene Gonzalez, Jeffrey A Sosman, Omid Hamid, Lynn Schuchter, Jonathan Cebon,[...]. J Clin Oncol 2016
203
25

Microsomal glutathione transferase 1: mechanism and functional roles.
Ralf Morgenstern, Jie Zhang, Katarina Johansson. Drug Metab Rev 2011
59
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.